Veltio

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Veltio's published strategy and is not endorsed by, or produced in cooperation with, Veltio. Company website

Strategic priorities

Veltio operates across 4 stated priorities, with the most concrete near-term plan anchored on sustainability leadership.

Positioning as the solvent-free, renewable material alternative to traditional spray-drying and freeze-drying methods, minimizing environmental impact through algae-derived porous cellulose.

Ensuring compatibility with standard, widely available industrial tablet press equipment to enable rapid technology transfer to any global CDMO without specialized machinery requirements.

Shortening time to market for poorly soluble drugs through direct compression technology that eliminates complex processing steps like rotary evaporation and cryogenic treatments.

Challenges we see

  • Operations Manufacturing

    CDMO Technology Transfer Gap

    Veltio relies on external CDMOs for production scaling but transfers technology to partners using legacy equipment lacking high-resolution data acquisition, creating a forensic nightmare when batch failures occur.

    When tablets fail dissolution standards, identifying root causes across compression force, humidity, or feedstock variability becomes impossible without real-time process data from partner sites.

  • Digital Integration

    Siloed Research Data Architecture

    Research data is trapped across university lab systems and local files at Uppsala, preventing scientists from accessing real-time performance data from tablet presses at remote partner sites.

    The IT/OT divide means meaningful data is only generated after batch completion rather than during processing, eliminating opportunities for real-time quality intervention.

  • Operations Operations

    Cognitive Overload from Manual Workflows

    A four-person team manually manages stability studies, in-vitro dissolution data, and animal trial results across 15+ substances, creating severe bottlenecks as the pipeline grows.

    Alert fatigue and cognitive overload from manual processing lead to missed insights in the data, potentially delaying critical decisions on formulation adjustments.

  • Compliance Regulatory

    FDA/EMA Regulatory Data Integrity

    Meeting FDA/EMA bioavailability standards requires proving consistent Tmax and Cmax values across batches, demanding tamper-proof data logging that paper-based or simple digital systems cannot provide.

    Without GAMP5-compliant automated data logging, Veltio faces compliance warning risks that could delay market approvals and damage investor confidence.

  • Digital Integration

    Intellectual Property Cybersecurity Exposure

    Veltio's entire valuation rests on ten patent families and proprietary algae cellulose compositions, yet technical transfers to global partners expose core IP without Zero Trust security protocols.

    As the company handles sensitive oncology and immune disorder drug data, a single data breach during technology transfer could severely damage company valuation and competitive positioning.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources
  1. Lab-to-Pilot Data Continuity

    Research data from Uppsala University labs does not follow substances through pilot-scale compression at partner sites, creating data gaps that slow troubleshooting and formulation optimization.

    Implement a digital thread architecture that captures analytical equipment outputs (XRD, DSC, FTIR, dissolution testers) and correlates them with production parameters across the entire development lifecycle.

  2. Real-Time Manufacturing Visibility

    Standard tablet presses at CDMO sites lack connectivity to Veltio's systems, preventing remote monitoring of critical process parameters like compression force that determine nanopore integrity.

    Deploy IoT-enabled process monitoring with OPC UA connectivity to create a unified view of manufacturing operations across distributed partner sites in France, US, and Mexico.

  3. Regulatory Compliance Automation

    Manual data management cannot provide the audit-ready, tamper-proof documentation required for FDA/EMA submissions proving consistent bioavailability profiles across production batches.

    Implement GAMP5/FDA-compliant automated data logging through bioprocess Control that ensures data integrity from sensor to regulatory submission without manual intervention.

  4. ESG Performance Tracking

    Veltio positions itself as a sustainable alternative to solvent-based methods but lacks automated systems to audit and document environmental claims across its decentralized supply chain.

    Build an ESG digital tracking platform that quantifies carbon footprint reduction versus traditional spray-drying, supporting investor relations and EU regulatory compliance (NIS2, CSRD).

  5. Secure Technology Transfer

    Sharing proprietary formulation data with global CDMO partners exposes critical intellectual property through unsecured technical transfer processes without identity-based access controls.

    Implement Zero Trust security architecture ensuring patent-protected compositions remain confidential even when shared with external manufacturing partners during technology transfer.

What we'd propose

  • Digital Lab

    Digital Lab Integration Platform

    A comprehensive data integration solution connecting Uppsala University research systems with pilot-scale production equipment to create smooth data continuity from discovery through manufacturing.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.
  • Digital CDMO

    CDMO Remote Monitoring System

    An IoT-enabled manufacturing visibility platform that connects Veltio to tablet press operations at partner CDMO sites, providing real-time process monitoring without requiring equipment replacement.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.
  • Enterprise AI

    GxP Compliance Data Platform

    A GAMP5/FDA-compliant data management system providing tamper-proof documentation and automated audit trails for regulatory submissions demonstrating bioavailability consistency.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.
  • Enterprise AI

    Sustainability Performance Portal

    An ESG tracking and reporting platform that quantifies and documents Veltio's environmental advantages over traditional solvent-based manufacturing methods across the distributed supply chain.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.
  • Enterprise AI

    Zero Trust IP Protection Framework

    A comprehensive cybersecurity architecture implementing identity-based access controls and encrypted data sharing to protect proprietary formulation data during technical transfers to CDMO partners.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what Veltio's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data Integration 25 → 80
Research data siloed across university systems and local files; no unified data platform connecting lab to production
Process Automation 30 → 75
Manual management of 15+ substance pipeline creates bottlenecks; no automated data pipelines from analytical equipment
Real-Time Visibility 20 → 85
No remote monitoring capability for CDMO production; data available only post-batch rather than during processing
Regulatory Compliance 35 → 90
Basic documentation exists but lacks GAMP5-compliant automated audit trails required for FDA/EMA submissions
Cybersecurity 25 → 80
No Zero Trust architecture for IP protection; technical transfers expose proprietary data without access controls
Sustainability Tracking 20 → 70
Environmental claims not backed by automated measurement; no ESG tracking infrastructure for NIS2/CSRD compliance

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Veltio, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].